Federal Register Notice: FDA’s Psychopharmacologic Drugs Advisory Committee and the Pediatric Advisory Committee will meet 9/13, from 8 a.m. to 6:30 p.m. and on 9/14, from 8 a.m. to 5 p.m. at the Holiday Inn, Bethesda, MD. The panels will discuss reports of the occurrence of suicidality (both suicidal ideation and suicide attempts) in clinical trials for various antidepressant drugs in pediatric patients with major depressive disorder and other psychiatric disorders. Contact Anuja Patel, (301) 827-7001. To view this notice, click here.
